M&A business
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is the weekly I am watching:
The 0.26 Level was tested twice and not broken. The second downtrend fom the old hihg is as well around 0.26 and the weekly bollinger as well. Seems to me all coming together.
http://investorshub.advfn.com/uimage/uploads/2015/6/2/g[xemUnbenannt.PNG
Well said - would fully subscribe to this.
Let's take the subject up again for discussion.
DECN could have made a deal in heaven actually. There are Young companies in Korea and Taiwan with AAA Ratings when it Comes to Technology. As a rule they are all well funded and blessed with smart People, agressive to have the lead when it Comes to new Generation products and known to produce very cost-conscious, so as to be competitive when it Comes to pricing.
But those companies as well want to conquer the world market with their innovative products and the USA certainly is one of the most attractive one.
DECN could have made a deal with such a Company in Korea and as well could have made a manufacturing deal but with another Company but maybe not in Korea?
Rebranding from the start with 2 new products and voila you enter a multibillion Dollar market backed by agressive enterpreneurs.
If it is, what some and I think it could be, DECN could be in for a very strong period of growing revenues. Now add to this, that a Settlement could be not far away and you are talking about a cash-rich small Company with totally new and rebranded products entering a well known Multi Billion Dollar market. I guess, the legal Brains who navigated DECN through the patent infringement case versus Lifescan/J&J may know what is legally needed or not needed to get the stamp of approval inside and outside of the USA.
To be a member of the Forum you have to pay and it is used of course to debate various companies from the Blue-Chip league around the world.
As J&J of course belongs to this league it is covered as well and what surprised me, that over the Weekend all of a sudden the subject DECN popped up. It happenes frequently that other companies are mentioned who are in clinch with J&J so this as such is not and was not the surprise. The surprise was, the line of thought about DECN having signed or signing a deal in Korea about manufactering a product and even rebranding.
As a matter of fact, to me it would not come as a surprise.
Then there of course is talk about Mediation as well and some legal Brains are of the opinion, that it could or would be in the interest of both parties to put this to an end. The way it is presented: This won't take much longer.
The closed Forum I am talking about is in the UK. You have to be a member to join and the reason they did it to Keep open a line for professional talk.
I do not think Korea is a rumour, I would rather rate it as a fact. Those People posting there are all ex employees from the Pharma industries or still employed , advisors and even lawyers and some must be analysts and Traders. So rather a well diversified crowd.
By the way, It is not only about the DECN it covers as well other cases J&J is involved and this covers more than 90 % of the discussions, but over the Weekend the subject DECN gathered momentum and as far as I am concerned it makes sense. Based on this I guess, it won't take very Long to get some News of substance.
Let's see.
Strange behaviour on Level 2 which Points to something being up. The ask side as actually empty and if buying should come in, this boring range will be over.
Based on various opinions I gathered in the closed Forums, there could be 2 Events making June a perfect start for the summer season.
DECN announcing a deal with a "big-company" out of Korea. This could stand for a new product under a different Kind of Name backed by a big Producer. Would this mean, the Elimination of the word Genstrip? Could very well be.
But another form of ping-pong is going on and this is: Let's settle here and now. Some legal minds are of the opinion, this could happen within the next 2 weeks as they try to decipher the smoke coming out of the court-dent and comparing this with other cases.
Excellent summary.
Just for the Statistic:
The traded volume in DECN for the period January - April 2015 was: 8.553.000 Shares.
This represents 19 % of the O/S within a period of 4 months.
Annualized 57 % Not bad I would say if I compare it with the Overall statistic of traded volume versus O/S.
I did not talk about the stock Price which as such will take care of itself when all pieces fit.
The Point was, that J&J approached DECN and not visa versa.
At least from my understanding, this is not something which should or would weaken the Position of DECN if both parties sit together and talk about ending the case.
Latest at this Point, when the word "ending" is in print, the market will become Aware of DECN and the consequences.
Until then - I feel relaxed.
I am sure, I am not in the wrong movie reading this again.
Decision Diagnostics Corp. (OTC PINK: DECN), the manufacturer, quality plan administrator and the exclusive worldwide sales, service and regulatory processes agent for the popular GenStrip™ 50, the FDA cleared Green Glucose Test Strip, specifically designed to work with the market leading Johnson & Johnson's LifeScan OneTouch Ultra family of glucose testing meters, today announced that the company was approached on May 12, 2015 by the Lifescan division of health industry giant Johnson & Johnson for the company's stipulation to Lifescan/J&J's offer to agree to a dismissal of several critical counts in the long running patent infringement suit between the parties. Lifescan/J&J's offer included that their lawsuit counts listed below each be DISMISSED WITH PREJUDICE:
1.All of LifeScan's lawsuit claims related to their '247 patent
2.All of LifeScan's lawsuit claims for monetary damages based on infringement related to their '862 patent
3.All of LifeScan's lawsuit claims for monetary damages based on their Lanham Act lawsuit
So the question again: Who approached DECN and offered to agree to a dismissal of several critical Counts? If I am right: It was Lifescan/Johnson & Johnson. And who is responsible that those Giant Company made this offer to a small cap Company? If my files are correct: Keith Berman - Ceo of DECN.
I know, it is not part of human character to give credit to whom credit is due.
New spring professional football league could have headquarters in Lakewood Ranch
Major League Football could come to Lakewood Ranch
By CLAIRE ARONSON
caronson@bradenton.comMay 22, 2015
Read more here: http://www.bradenton.com/2015/05/22/5812618_new-spring-professional-football.html?rh=1#storylink=cpy
http://www.bradenton.com/2015/05/22/5812618_new-spring-professional-football.html?rh=1
More to come in the weeks ahead. Stay tuned.
Major League Football Awarded Economic Development Incentive From Manatee Board of County Commissioners
Major League Football Enticed to Consider the City of Lakewood Ranch, Florida for Its Headquarters and Training Facilities
http://finance.yahoo.com/news/major-league-football-awarded-economic-133000116.html
As somebody more sophisticated on this subject than I am, posted the following:
It seems to me that since J&J dismissed their suit with Prejudice, DECN should be able to collect attorney's fees as a result of the dismissal. A dismissal with Predjudice makes J&J a loser in this case and attorney fees are a matter of law. It looks like J&J will begin paying shortly. A million or two would be a nice start.
My comment to this: More than a nice start, because those fees have been part of expenses and they are booked and paid and if the flow of Money now reverses DECN could then book those amounts on the income side which of course would increase the cash-Position. Always nice to see, Money returning home.
Have not seen a public Company in this world involved in a legal battle, that would not Need a Coach to go through this Kind of process. Being wedged between "inactivity" and planning "activity" due to a litigation battle as DECN goes through, you are not only surving with lawyers you as well Need Consultant(s) covering the Business side in preperation and then as well Consultants playing the neutral advisors between the Company and the legal minds. Wondering then, why the subject Consulting expenses should be something to put the finger in a negative way on it.
However, I am very glad to see the amounts in the filings as those amounts will certainly be a part when the amount of Settlement is negotiated. Costs in relation to this case - being this legal costs, costs for not being able to execute Business, costs for compensating advance R&D, costs for Exit strategies and so on, will all be put into the basket.
As was written here in another post:
Currently this case is in the investment grade silver part of the continuum, trending quickly toward gold. And gold is where this case will be settled.
Can only add to this: And it will mean Gold for the shareholders. And by the way: A CEO is only interested in Options when he sees the value of the underlying stock to go up many times. If not so, there would be other and better alternatives to cash in big.
Last but not least, I recommend to study the rule 144 and more when it Comes to selling stocks as an affiliate or as a CEO.
Trading Volume Formula. If you are an affiliate, the number of equity securities you may sell during any three-month period cannot exceed the greater of 1% of the outstanding shares of the same class being sold, or if the class is listed on a stock exchange, the greater of 1% or the average reported weekly trading volume during the four weeks preceding the filing of a notice of sale on Form 144. Over-the-counter stocks, including those quoted on the OTC Bulletin Board and the Pink Sheets, can only be sold using the 1% measurement.
Reading between the lines:
. If J&J finally loses the '105 patent now under appeal, they will not have any patent protection or their One Touch Ultra product. What do you think would happen?
And
This strategy will work for J&J until the day that they lose that '105 patent. Then the strategy will backfire big time.
This is the big question: When will J&J finally lose the 105 patent which is now under Appeal?
The ongoing debate if DECN would qualify or not for an uplisting to QX because their financials are not audited can be solved by studying the various rules that cover this subject.
DECN qualifies without any questions. I recommend to read this very carefully so as to understand, why they qualify.
Alternative Reporting Standard: When SEC registration is not required, companies must generally still make information publicly available pursuant to Federal securities laws, including Rule 10b-5 under the Exchange Act and pursuant Rule 144(c)(2) under the Securities Act. OTC Markets Group offers the Alternative Reporting Standard for companies who choose to make material information publicly available to investors
OTCQX U.S companies not reporting to the SEC can follow the Alternative Reporting Standard. These companies submit information pursuant to the OTCQX U.S. Disclosure Guidelines and are subject to the eligibility requirements and terms of the OTCQX Rules for U.S. Companies. OTCQX companies provide current and potential investors with a set of "material" information to help investors make a sound investment decision. OTCQX company disclosure enables an investor to understand the company’s business operations and prospects
OTC Pink companies may publish disclosure in accordance with the OTC Pink Basic Disclosure Guidelines. These requirements are designed to give an investor the basic information a broker-dealer must maintain under Exchange Act Rule 15c2-11 in order to initiate a quote in a security on the OTCQX, OTCQB or OTC Pink marketplaces.
Finally: I could put here a list of about 20 companies which were uplisted based on this rule, and I am talking about US companies.
The parameteres (ranges) are set. Until 0.27 broken on the upside Zero momentum and of course once above 0.47 the stock will challenge again the old highs. Actually a paradise for MM's to Play the stock within narrow Limits and it is obvious were there stops are. Look at the 0.27 Level in 2013 - Held almost for 9 months and once broken, the Boys had to run after.
http://www.otcmarkets.com/marketplaces/otcqx
OTCQX Logo
The Best Marketplace
Designed for investor-focused companies that meet high financial standards, are current in their disclosure and receive third party advisory. The companies found on OTCQX are distinguished by the excellence of their operations and diligence with which they convey their qualifications.
To view the full list of world-class OTCQX companies click here.
Companies can learn more about qualifying for the OTCQX marketplace, here.
A complete list of OTCQX Advisors, including Designated Advisors For Disclosure (DADs), Principal American Liaisons (PALs), & Corporate Brokers, can be found here.
OTCQX Benefits for Investors
Investors can see prices and access market data – OTCM sets the best price standard by broadly distributing our market data through multiple channels, including Bloomberg, Thomson Reuters, and other leading market data distributors.
Investors can access company information – OTCM’s suite of Corporate Services empowers public companies and their advisors to improve visibility and availability of information.
Investors can trade through the broker of their choice – OTCM’s technology enables investors to buy and sell securities through the institutional, retail, or online broker-dealer of their choice, making the trading experience nearly identical to that of trading NYSE or NASDAQ securities.
Key Highlights About the OTCQX Marketplace*
300+ world-class companies (ranging from global blue chips to U.S. high growth)
$1.7 Trillion in market capitalization
$29.5 Billion in annual dollar volume
$78 Million in average annual dollar volume per security
Radio-Interview with Wes Chandler
Wes Chandler, President - The President of Major League Football was a two time consensus football and academic All-America selection in 1976 and 1977 at the University of Florida. Mr. Chandler was one of the top receivers in both collegiate and professional football. Drafted by the New Orleans Saints with the 3rd overall selection in the 1978 NFL Draft, this four-time Pro Bowl performer has over 30 years of football experience that include 11 NFL seasons as a player, coaching stints in NFL Europe and the NFL with the Cowboys, Vikings and Browns. One of his crowning achievements was his induction into the San Diego Chargers Hall of Fame in 2001.
http://www.750thegame.com/wes-chandler-major-league-football/
I am not so sure that the "Anti-Decn" crowd will have a lot to smile once the full text is read and digested.
And what they may have overlooked, the August 2016 is not a date written in Stone. As in any court, dates are issued as guidance, however in between something could happen, that J&J wishes that all would be over.
Last but not least: I still try to find the Definition why a 10 % correction should be considered a collapse.
http://finance.yahoo.com/news/major-league-football-targets-birmingham-130000467.html
Major League Football Targets Birmingham, Alabama for Spring Football Franchise
Company in Discussions With Legion Field as Venue
DECN acquired 2 patents. Everybody who did some R&D will know what those 2 patents are all about. Based on some readings I did and some second opinions I got in, the amount in question could be calculated up for a period of 5 to 6 years. Or as Play4keeps2 mentioned, include a lookback period of 6 years. Now, going deeper into Details, then it is easy to get to the figure J&J made - based on those patents over those period - and "in case" J&J infringed those patents (and there are some legal opinions around who say so) then of course the amount is fixed. You cannot delete your own financials, that is the good Thing at the end and what is even better, the financials cleary Show, how much J&J made over the last 5 to 6 years based on those patents. (In case of course they infringed it)
But then again, those who made a proper DD will know, what Kind of value those 2 patents could be for DECN if and when of course all legal opinions are analysed and then decided by court.
However and it took me again 2 second legal opinions about what it is all about and their Statements were clear; it could be one of the smartest moves acquiring those patents but then as well luck because of the ignorance of J&J.
Why:The seller did not want to sell to J&J this is a fact as they turned a cold shoulder versus the seller. The seller did not have the Money to go Forward and the seller did not have the legal backing, as DECN has, to take the risk. But DECN has proven all over the last 3 years, that their legal backing is not from yesterday, but actually ahead of the game. But Comes to it, you Need as well the financial backing to go synchron with the legal minds and this is what DECN has and got.
To make the Story short here: Those 2 patents could catapult DECN into a league which most cannot imagine.(But it would be easy to publish some Settlement figures of similar cases ) Those who did the proper DD - and I will not be the one Publishing it here - will know what Kind of Money is on stake. If only 10 % of this amount is spoken, it will add Minimum $ 10.-- to the stock.
I guess, down the road, it will dawn to some, that those who up to this date bought the stock in big numbers and financed the Company, had not only the understanding what it is all about by turning the tables but then to refuse the Settlement and by financing this acquisition. Smart - smart.
Comes to it: If it would come to a fight about the total owed amount with reference to this 2 patents, some big Boys from the Coast, famous for financing such a litigation cases, would not have to be asked twice to finance it, because everybody understanding who those litigation funds work, would know, that they cash in between 25 and 35 % of what finally is paid. And those litigation funds are not know to be stupidn. So, fasten your seatbelts for this Kind of war, which certainly will take place if J&J does not get the message.
Thanks for this one. Now I recall this Statement from "S" - Turning the tables and what it actually meant.
Litigation Funds would falling over each other to be part of this struggly against J&J and Headlines in the press would be guaranteed.
Your saying: The $277K DECN invested to purchase these patents could be one of the best investments ever!!
Or in Wallstreet Terms, the perfect leverage on a perfect trade.
Those 2 patents could become a nightmare for J&J. Don't you think so. Smart move from K.B. CEO of DECN. They maybe wondering what has hit them.
But the strategy could as well be:A message to J&J: Offer a fair Settlement and versus this we are open to negotiate about those patents. Presently DECN certainly has the better Cards to win this game in a big way.
This Master Witness from Johnson and Johnson seems to have been an expert in all fields. Expert for the Pharma Industry and damage expert for the payment solutions industry. The legitime question is then, what kind of selection criterias J&J had, when they were trying to find somebody to play their dirty game against DECN? I tell you which one: They searched for a guy with an impressive CV and then told him what he has to testify of course against a huge payment. This is what is called "Bribe".
Reading the letter below where it says: "numerous other cases", should ring the bell. In plain Englisch it says: This was a professional wittness and we all know what this means: Testifiying in favour of the highest bidder.
Here Another company who had the luck to hire this guy.
RE: First Data Merchant Services Corp., et al. v. SecurityMetrics, Inc.
Civil No. RDB-12-2568
Dear Counsel:
The Plaintiffs and Counter-Defendants First Data Merchant Services Corporation and First
Data Corporation notified this Court on December 18, 2014 that their damages expert, Richard Gering,
had misrepresented his academic background despite having testified under oath to that background in
numerous other cases (ECF#331). Accordingly, this Court scheduled a telephone conference
addressing this matter. It was during this telephone conference on December 22, 2014 that First Data
acknowledged that it would be withdrawing Mr. Gering as an expert witness and indicated it would
seek to replace him.
https://cases.justia.com/federal/district-courts/maryland/mddce/1:2012cv02568/209894/341/0.pdf
And not to be forgotten. The stock is working itself slowly higher.
Ksviking12 excellent find and it Shows what proper DD can produce. Opponents of DECN won't like this at all.
Seems to me a pattern J&J is using in court: Producing a fake witness in various cases and then Play innocent.
I already see the smile on the faces of DECN's lawyers and Management.
What should be bad about stockoptions? As a matter of fact, it is good for a Company from an accounting Point of view and for the Receiver it is certainly the best motiviation to bring a Company Forward and to create shareholder-value.
So how is it affecting the balance-sheet?
Somehow it dependes which method is used.
The two methods to calculate the expense associated with stock options are the "intrinsic value" method and the "fair-value" method. Only the fair-value method is currently U.S. GAAP. The intrinsic value method, associated with Accounting Principles Board Opinion 25, calculates the intrinsic value as the difference between the market value of the stock and the exercise price of the option at the date the option is issued (the "grant date"). Since companies generally issue stock options with exercise prices which are equal to the market price, the expense under this method is generally Zero
The mathematical formula such as the Black-Scholes model, which requires various assumptions as inputs. This method is now required under accounting The fair-value method uses either the price on a market or calculates the value using a rules
Conclusion:
Stock option expensing is a method of accounting for the value of share options, distributed as incentives or salaries to employees, within the profit and loss reporting of a listed business. On the income statement, balance sheet, and cash flow statement say that the loss from the exercise is accounted for by noting the difference between the market price (if one exists) of the shares and the cash received, the exercise price, for issuing those shares through the option.
Opponents of considering options an expense say that the real loss- due to the difference between the exercise price and the market price of the shares- is already stated on the cash flow statement. They would also point out that a separate loss in earnings per share (due to the existence of more shares outstanding) is also recorded on the balance sheet by noting the dilution of shares outstanding. Simply, accounting for this on the income statement is believed to be redundant to them.
But they Forget, that Managements that are paid with Options have a stronger interest to create shareholder value than those only paid in cash. The reasons and the logic behind I think is very obvious as Options only gain in value if the stock gains in value.
For companies as such issuing options is rather better than issuing bonus in Cash or other Kind of compensation in cash. . Cash Is a precious commodity and leaves the bank and is of course booked as expense. The booking as such takes place with options as well, but no money leaves the bank. A lot of young companies with strapped liquidity are happy to sign options agreements with their management. If the management agrees, it is actually a sign of confidence – the same with DECN – as options only are getting valuable if the company does well and the stock goes up. With this kind of strategy a lot of young enterpreneurs became wealthy and I wish the same will happen to K.B. as well. He took the risks when Standing up against J&J and therefore he deserves rewards as well, once the case is closed.
2 Items - Causa AHN (Access Health Net) and Options compensation.
Clarification for the avoidance of doubt and in the hope, that this ever construed and repeated story around the Chapter 7 of AHN in 1996/97 will find its end.
Proper Due-Diligence would demand the full study of all court documents available and they are available, however just with posting a link that presents the start and the Settlement, but not the breakdown of the judgement, the story of course Is not and cannot be complete because it would show, that K.B. was not found guilty and more there is no documents that shows, that K.B. had to pay anything, but to come up for his legal fees. One should know the difference between accusation and judgment. If of course somebody Ends the story with the chapter accusation then the field is open for stories but if one takes the time and reads then as well the judgment (what proper Due-Diligence actually would demand) then the “possible story” becomes a “Non-Story.”
And what is more important, there is no document and evidence that the SEC got involved. So the question would then be: How bad could it really have been?
The same pattern we see with the Chapter 11 and Chapter 7 cases in the Airline Industry and Automobile Industry, the SEC never got involved. Why should they?
Here a summary of the case from 1997.
Behind the class action was Willy Lerach, famous lawyer for such kind of acts, but later on he had to go to jail by himself. But he is and was not the only “moralist” to crusaded against companies but at the end got caught because of not being able to distinguish between what is mine and what is hers.
When the class action suit was over, 3 were found guilty and forced to pay.
-The Hedge Fund major shareholder who was guilty of stock manipulation, pumping on the way up, bashing and shorting on the way down, while running AHN as Chairman and CEO, actually forcing out the founders, the officers and directors, by naming his own directors.
- the auditing firm where in the middle of an annual audit, the auditing partner left his firm in return for a $500,000 bonus and joined AHN as their Executive VP and CFO. The auditing firm's insurer paid their judgment, the largest payment in the case, and the newly minted Executive VP and CFO lost his CPA license when his junior partner at the CPA firm became whistle blower.
- The only person who went to jail was an investment manager from Beverly Hills, CA who raised money for AHN under the formula of one for me and one for them, two for me and one for them. He copped a plea and spent 4 years in Jail
Conclusion:
I can find nowhere in all documents that Mr. Berman was held accountable for anything and that he had to pay anything into the settlement amount. Everyody would know I guess, the differene between accusation and judgement. Everybody can sue anybody any day but then the buck stops here. All what he had to pay for where his personal legal fees, this is all. The reason is clear as well when studying the court paper: At the time when the mess took place that was later on responsible for the class-action suit by the shareholders, K.B. was not in charge. All documented and very well documented in those court papers.
SUBJECT OPTIONS.
Another Story always good to debate is Stock Options. If understood then actually it should be a non-event, however if not understood then it becomes complicated for those. There is no NYSE company listed where we cannot see issued or granted options for employees (bonus related) or management or board.
Actually a chart shows, that options from a balance-sheet point of view are the cheapest form. The most expensive one is the cash-compensation – as money flows out of the account – or then outright stock-compensation. At the low end of the chart we have the options-compensation. Those familiar with the revisions from GAAP versus pro forma earnings will know what I am talking about.
Chapter 7 in 1996 and now we have 2015. If am counting right your are posting something from almost 20 years back but you forgot to post, that this whole case was settled.
Case Status: SETTLED
On or around 01/22/2001 (Date of order of final judgment)
Mr. Berman was not found guilty on anything, compared to 3 others who were found guilty of being neglect and had to pay a very substantial amount for the case to be settled. The amount K.B. had to pay was so small, that one could not even compensate a good lawyer for a week's work.
However, chapter 7 and chapter 11 stories are not that unique in the industry if one thinks only of the Car-Industry and the Airline Industry. So why it should be of interest in the case of DECN I cannot follow unless of course it was meant against the present CEO of DECN who is doing an excellent job at various fronts. J&J could and would certainly confirm that.
Last but not last; I expect soon "the Upgrade" where it then will say: OTCQX Or as OTC says on their Webside: the best marketplace for the best companies.
And here is the list of all world-class companies who are members of QX.
http://www.otcmarkets.com/research/otcqx-company-list
Independent Oregon Duck Sports News and Analysis Including Oregon Duck Football, Basketball and Baseball
http://fishduck.com/2015/04/former-ducks-could-be-suiting-up-in-autzen-once-again/
Israel is a small country and everybody knows each other. Of course as everybody has to serve in the army for years. But then Israel is known to be the Nr. 2 after Silicon Valley as they are not short of talents when it comes to technology or everything healthcare related. They have a talent pool of young Russian brains who moved there or to the USA. People from well known foreign companies are visiting on a regular basis this country either to pay a visit to their R&D branches there or to tap talents of young bright people and so, the rumour mill at the right places in Tel-Aviv is like a fast trade. Came not as a surprise then to learn, that somebody from DECN paid a visit to this country because the person was invited and now is preparing a trip to Korea to meet a partner and then to Taiwan to meet another partner. Could it be, that this is in connection with a convoluted statement from the CEO on March 4.th 2015
The company, more importantly, is announcing that the preparation for an expected explosion of product demand following legal victory has already begun. Solicitations for interview and quotation have been circulated to various internationally certified and FDA approved manufacturers for the contract manufacture of GenStrip™ 50. The time frame for tooling creation, first article part delivery and full product production is expected to fall within a five to seven month timeframe, following the final selection of an international contract manufacturer. Concurrent to the fulfillment of supplemental GenStrip™ 50 manufacturing, that selected manufacturer will simultaneously be charged with the completion of a new product that has been under internal development for nearly a year. Several of these manufacturing candidates are currently manufacturing second generation, FDA cleared, embryonic versions of the company's (3rd generation) product concept.
Could then be the purpose of those rumoured visits be in relation with Genstrip on one hand, but then on the other hand as well cover the release of a totally new product? The axis – Israel – Korea – Taiwan – in the field DECN is operating, opens the door for both? One should be aware, that the 4 AsianTigers of Hong-Kong, Singapore, South Korea and Taiwan, have the strongest economic growth, because they serve not only the mainland China, they serve the rest of the world. So, for every forward looking entrepreneur in the field of Healthcare there is a pattern to follow that covers the intellectual property of the technology, that covers the development and production and finally that covers the distribution. Could it be we are in for some very pleasant surprises going into the summer?
Some thoughts and some Charts.
I would say we can agree on one thing. DECN is a very unique company. There was a time, DECN was on the radar of some powerful media- magazines, but then, the excitement slowed down, as the case DECN versus J&J took longer than expected. But what was the expectation? As times went by rather on the side, that DECN would get crushed as so many other companies who got in clinch with the biggies. The chorus of course was plausible: Running out of money and as well-being cornered by the high paid legal teams, such companies can afford.
But we all know, it took another turn. DECN beat the hell out of J&J and J&J was faced with a 3 times guilty verdict by USTPO. As a remainder, this is a Federal Agency. But then we know as well, that J&J tried to buy DECN by offering an amount, which DECN refused. Not surprisingly of course, J&J not used to be a loser or to get a no, tried another game just to be reminded by another Federal Agency , The Solicitor General of the USA, that enough is enough and let them know, that this agency intends to intervene in the USA Court of Appeals for the Federal Circuit.
Maybe some still have not gotten the message what this means: The office of the Solicitor General will now join the Pharma Tech (DECN) attorney to get to the bottom of all this.
If J&J is considered to have deep pockets then I would say, I prefer the deep pockets of the government of the USA and for certain, the USTPO (as well a Federal Agency) certainly does not like that somebody makes a fool out of them or their decisions.
This will – once it’s over – write history and lawyers will be all over to take this case up, but then the same will be done by the medias like Forbes, Business-Week, Wallstreet-Journal and more and this will catapult this small company into the headlines. And investors and traders are quick when it comes to press a buy-bottom if they see the value ahead.
With the present O/S of roughly 46 Mio shares, DECN has a market-cap of $ 10 Mio . This of course leaves plenty of room to the upside and actually is a gift: J&J’s “panic” behaviour in this patent case shows the potential value of the market DECN would like to have a piece of it. And stealing a small company 4 years of planning and execution will have to be added up when it comes to the question: What is a fair settlement price? J&J no longer can steal itself through the backdoor with a settlement amount not taking all into consideration as such a presentation would be provocative for every legal system. Why then spending millions in dollars, wasting precious time of courts and employ countless of judges and clerks in a case that represents no value. Forbes in their September 2013 issue gave the answer: Why the big fight over the testing strips? The diabetes testing market worldwide is estimated to be about a $23 billion yearly business, and experts estimate that by 2017, that market will grow to $30 billion. Among the diabetics who have tested their own glucose levels at home on a daily basis, some 3.4 million use or have used J&J’s Ultra meters.
You can never plan the future by the past but you can observe it and act before it occurs. With this kind of thinking, some Silicon Valley Boys got rich. What is ahead for DECN or what should we expect in the weeks ahead.
1.) News about an acquisition of assets
2.) News from the court front
3.) Settlement
4.) Private Label Contracts in the USA
5.) Contracts with Retailers in the USA
6.) Manufacturing agreements outside of the USA
7.) Deals outside of the USA.
8.) New products and more.
In which order the news will come out is anybody’s guess, but they will come out and all those news will add value. For sure, the final nail into this saga will certainly be, once the ink is dry under a settlement and good old Dollars are flowing into the treasury of DECN and put an end to dilution, but as well take away the uncertainty which is always a part in the brains of investors.
The weekly chart shows an excellent picture, reflecting the emotions of the crowd. There is nothing wrong to say, that we are building some very strong base here under the 0.30 level, which in the future will then be considered the bottom of some kind.
Of course they pay and as a matter of fact maybe already paid all.
According to the 10K - they paid 80.000 Shares and 100.000 shs.
If Stradley sold them around $ 1.-- he made $ 180.000.-- Maybe he did not sell all and demands a compensation to fill the gap. Maybe another 50.000 or 100.000 Shares.
From the filing:
In
addition to previously issued 80,000 shares of common stock, on July 14, 2014, the Company issued 100,000 shares of common stock to
Stradley and previously issued 80,000 shares of common stock to Stradley and is in discussion with the law firm to resolve the Judgment and
anticipates a resolution in the near future. (See Note 6 – Capital Share Transactions).
And as logic follows, after the defintive APA with MLFB was signed in 2014, the following next step was taken.
On November 12, 2014, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the
State of Delaware to change its name to Major League Football, Inc. from Universal Capital Management, Inc. The Certificate of Amendment
became effective at 5:00 p.m. EST on November 24, 2014.
Reading filings is a complex matter but if done, a lot of questions could be avoided. For example why the Name Change to MLFB in 2014.
Of course, you cannot operate under a Name when the legal Parameters are not set. But in 2014 everything was signed.
Very clear and part of the 10K
On July 14, 2014, our Company entered into and closed a definitive Asset Purchase Agreement with Major League Football, LLC, a
development stage company formed in 2009 to establish, develop and operate a professional spring football league to be known as "Major
League Football" ("MLFB").
Read more in the filings and then you will find, that they paid the attorney.